Domijan Ana-Marija, Peraica Maja, Vrdoljak Ana Lucić, Radić Bozica, Zlender Vilim, Fuchs Radovan
Unit of Toxicology, Institute for Medical Research and Occupational Health, Zagreb, Croatia.
Mol Nutr Food Res. 2007 Sep;51(9):1147-51. doi: 10.1002/mnfr.200700079.
The aim of this study was to find out whether very low doses of nephrotoxic and hepatotoxic mycotoxins ochratoxin A (OTA) and fumonisin B1 (FB1) induce oxidative stress in rat kidney and liver and whether their effect is synergistic. Rats were treated orally with OTA (5 ng/kg b.w. and 50 microg/kg b.w.) and FB1 (200 ng/kg b.w. and 50 microg/kg b.w.), or their combinations. Malondialdehyde (MDA) and protein carbonyls (PCs) concentration in kidney was affected with lower dose of OTA than in liver (p<0.05). FB1 did not affect MDA and PCs concentrations in the liver, while in the kidney both FB1 doses increased MDA concentration (p<0.05). The combination of the lower doses of OTA+FB1 increased the MDA and PCs concentration both in the liver and the kidney, compared to controls and animals treated with respective doses of mycotoxins (p<0.05). The combinations of mycotoxins reduced the catalase activity only in the kidney when compared to controls (p<0.05). In contrast to the increased kidney concentrations of MDA and PCs even with very low doses of OTA and FB1, the activity of catalase and SOD does not change. Combinations of OTA+FB1 affected almost all parameters, which indicates their potential to produce oxidative damage.
本研究的目的是探究极低剂量的具有肾毒性和肝毒性的霉菌毒素赭曲霉毒素A(OTA)和伏马菌素B1(FB1)是否会在大鼠肾脏和肝脏中诱导氧化应激,以及它们的作用是否具有协同性。给大鼠口服OTA(5纳克/千克体重和50微克/千克体重)和FB1(200纳克/千克体重和50微克/千克体重)或它们的组合。肾脏中丙二醛(MDA)和蛋白质羰基(PCs)的浓度受较低剂量OTA的影响程度大于肝脏(p<0.05)。FB1对肝脏中的MDA和PCs浓度没有影响,而在肾脏中,两种FB1剂量均增加了MDA浓度(p<0.05)。与对照组和用相应剂量霉菌毒素处理的动物相比,较低剂量的OTA+FB1组合增加了肝脏和肾脏中的MDA和PCs浓度(p<0.05)。与对照组相比,霉菌毒素组合仅降低了肾脏中的过氧化氢酶活性(p<0.05)。与即使使用极低剂量的OTA和FB1也会增加的肾脏MDA和PCs浓度相反,过氧化氢酶和超氧化物歧化酶的活性没有变化。OTA+FB1组合几乎影响了所有参数,这表明它们具有产生氧化损伤的潜力。